Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/46158
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Turkmen, Nese Basak | - |
dc.contributor.author | Yuce, Hande | - |
dc.contributor.author | Taslidere, Asli | - |
dc.contributor.author | Sahin, Yasemin | - |
dc.contributor.author | Ciftci, Osman | - |
dc.date.accessioned | 2023-01-09T21:09:41Z | - |
dc.date.available | 2023-01-09T21:09:41Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1304-530X | - |
dc.identifier.issn | 2148-6247 | - |
dc.identifier.uri | https://doi.org/10.4274/tjps.galenos.2021.30806 | - |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/525070 | - |
dc.identifier.uri | https://hdl.handle.net/11499/46158 | - |
dc.description.abstract | Objectives: Thioacetamide (TAA) is an organosulfur, white crystalline compound having liver injury. However, it shows toxic effects on many organs. The reverts the oxidative stress created by TAA on the heart and kidney, and decreased lipid peroxide peroxidation back with antioxidant-properties nerolidol (NRL). This study hypothesized that NRL treatment a potential ameliorate nephrotoxicity and cardiotoxicity caused by TAA. Materials and Methods: Thirty-two Wistar Albino male rats (3-4 months old and 280-300 g in weight) were divided into four groups. (a) Control, (b) TAA was administered 200 mg/kg i.p. twice a weekly (c) NRL was orally administered at the dose of 100 mg/kg per every other day by savages. (d) TAA and NRL-treated groups were assigned 200 mg/kg TAA and 100 mg/kg NRL for three weeks. Results: As a result of these dose administration thiobarbituric acid reactive substances (TBARS) levels, superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and glutathione peroxidase (GPx) levels were detected. The results were shown that TAA leads to a significant rise in TBARS level and a significant decrease in GPx, CAT, SOD, and GSH levels in the heart and kidney tissue according to the control group. The finding of this study the NRL treatment reduced TBARS levels and increased antioxidant level. Administration of NRL prevents the biochemical and histopathological alterations induced by TAA. Conclusion: The findings of this study show that the antioxidant activity of NRL can protect against biochemical and histological damage caused by TAA in heart and kidney tissue. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.relation.ispartof | Turkish Journal Of Pharmaceutical Sciences | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Nerolidol | en_US |
dc.subject | thioacetamide | en_US |
dc.subject | lipid peroxidation | en_US |
dc.subject | nephrotoxicity | en_US |
dc.subject | cardiotoxicity | en_US |
dc.subject | Essential Oil | en_US |
dc.subject | Chemical-Composition | en_US |
dc.subject | Antioxidant | en_US |
dc.subject | Injury | en_US |
dc.subject | Nephrotoxicity | en_US |
dc.subject | Activation | en_US |
dc.subject | Stress | en_US |
dc.subject | Leaves | en_US |
dc.title | The Ameliorate Effects of Nerolidol on Thioacetamide-induced Oxidative Damage in Heart and Kidney Tissue | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 19 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 1 | en_US |
dc.identifier.endpage | 8 | en_US |
dc.authorid | Taşlidere, Aslı Cetin/0000-0003-3902-3210 | - |
dc.authorid | yuce, hande/0000-0003-2907-2019 | - |
dc.authorid | Ciftci, Osman/0000-0001-5755-3560 | - |
dc.identifier.doi | 10.4274/tjps.galenos.2021.30806 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57211524435 | - |
dc.authorscopusid | 57222505412 | - |
dc.authorscopusid | 57192546285 | - |
dc.authorscopusid | 57209747802 | - |
dc.authorscopusid | 27867577100 | - |
dc.authorwosid | Taşlidere, Aslı Cetin/AAB-3979-2021 | - |
dc.identifier.pmid | 35227035 | en_US |
dc.identifier.scopus | 2-s2.0-85125576224 | en_US |
dc.identifier.trdizinid | 525070 | en_US |
dc.identifier.wos | WOS:000767290000001 | en_US |
dc.identifier.scopusquality | Q3 | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
The Ameliorate Effects of Nerolidol.pdf | 4.02 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
14
checked on Nov 23, 2024
WEB OF SCIENCETM
Citations
13
checked on Nov 21, 2024
Page view(s)
82
checked on Aug 24, 2024
Download(s)
28
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.